Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases

NCT03497767

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Calvary Mater Newcastle, New South Wales, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • St. Vincents Hospital Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

NCT04426825

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Hospital; Internal Medicine-Oncology Beijing, China
  • Beijing Chest Hospital; Oncology Department Beijing, China
  • West China Hospital, Sichuan University Chengdu, China
View Trial Details
Completed

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

NCT03001882

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0006 Springdale, Arkansas, United States
  • Local Institution - 0001 New Haven, Connecticut, United States
  • Local Institution - 0005 Jacksonville, Florida, United States
  • Local Institution - 0009 Atlanta, Georgia, United States
View all 35 locations
View Trial Details

Related conditions